However, it is described that tumor cells express PD-1 and PD-L1, which inhibit tumor cell growth by impairing AKT and ERK1/2 pathways and preventing the interaction with PD-1-expressing T cells [191]. This evidence concerns the gene MAPK3 and neoplasm.